Published in Am J Cardiol on December 01, 1991
Studies of Left Ventricular Dysfunction (SOLVD) | NCT00000516
Changes in heart failure medications in patients hospitalised and discharged. BMC Fam Pract (2006) 0.83
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet (2000) 8.01
Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. Radiology (1988) 7.26
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ (2001) 5.63
Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med (2000) 5.41
A systematic review of randomized trials of disease management programs in heart failure. Am J Med (2001) 5.38
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med (2000) 5.34
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Randomised, controlled trial of efficacy of midwife-managed care. Lancet (1996) 4.21
Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA (1993) 4.01
End-of-life decisions in neonatal intensive care: physicians' self-reported practices in seven European countries. EURONIC Study Group. Lancet (2000) 4.01
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation (1996) 3.98
Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Arch Dis Child Fetal Neonatal Ed (1999) 3.14
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA (2000) 3.12
Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med (1998) 2.80
The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol (1999) 2.79
Randomised controlled trial of routine cervical examinations in pregnancy. European Community Collaborative Study Group on Prenatal Screening. Lancet (1994) 2.74
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol (1996) 2.60
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med (2000) 2.57
The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med (2000) 2.44
Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36
Medical genetic services in 31 countries: an overview. Eur J Hum Genet (1997) 2.33
Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ (1997) 2.23
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J (2001) 2.22
Should euthanasia be legal? An international survey of neonatal intensive care units staff. Arch Dis Child Fetal Neonatal Ed (2004) 2.21
Treatment choices for extremely preterm infants: an international perspective. J Pediatr (2000) 2.19
Improved outcome for prehospital cardiopulmonary collapse with resuscitation by bystanders. Circulation (1977) 2.12
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol (2001) 2.12
Acute precipitants of congestive heart failure exacerbations. Arch Intern Med (2001) 2.11
One-year survival following early revascularization for cardiogenic shock. JAMA (2001) 2.10
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation (2001) 2.09
Drug misusers in Lothian: changes in injecting habits 1988-90. BMJ (1993) 2.09
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation (2001) 2.05
The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA (1995) 2.03
Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med (1998) 2.01
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol (1997) 1.97
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation (1991) 1.96
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet (2004) 1.94
Iatrogenic rickets in low-birth-weight infants. J Pediatr (1971) 1.90
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation (1993) 1.86
Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging. Circulation (1994) 1.84
Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J (1999) 1.75
Noninvasive quantification of left ventricular rotational deformation in normal humans using magnetic resonance imaging myocardial tagging. Circulation (1990) 1.74
Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol (1981) 1.74
Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med (1979) 1.73
Genomic in situ hybridization to identify alien chromosomes and chromosome segments in wheat. Theor Appl Genet (1992) 1.72
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) (2005) 1.72
Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics (1992) 1.71
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation (2000) 1.69
What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence. Sex Transm Infect (2007) 1.68
Spinal manipulation in general practice. Can Fam Physician (1993) 1.68
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol (1999) 1.59
Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of an enzymatic digestion procedure. Clin Exp Immunol (1986) 1.57
Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation (1997) 1.56
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. Circulation (1995) 1.56
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol (1996) 1.55
Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry (1998) 1.51
Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol (1996) 1.51
Coagulation and fibrinolytic changes in evolving acute myocardial infarction treated by high-dose, brief-duration intracoronary or intravenous streptokinase. Am J Clin Pathol (1990) 1.51
Better functional status in American than Canadian patients with heart disease: an effect of medical care? J Am Coll Cardiol (1995) 1.50
Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat Med (1990) 1.50
Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol (1993) 1.49
Neonatal end-of-life decision making: Physicians' attitudes and relationship with self-reported practices in 10 European countries. JAMA (2000) 1.49
Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989) Am J Cardiol (1991) 1.48
Dissociation between left ventricular untwisting and filling. Accentuation by catecholamines. Circulation (1992) 1.48
Aberrant anatomy of the hypoglossal nerve. J Laryngol Otol (2012) 1.48
Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation (1979) 1.47
The distribution of rods and cones in the retina of the cat (Felis domesticus). J Comp Neurol (1973) 1.47
Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys (1998) 1.46
Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol (1992) 1.45
Use of GUM services and information and views held by first time service users in a large UK city: implications for information provision. Int J STD AIDS (1997) 1.44
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol (1994) 1.43
Effects of nerve growth factor on nerve regeneration through a vein graft across a gap. Plast Reconstr Surg (1999) 1.43
Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation (1998) 1.43
Stability of positive tuberculin tests: are boosted reactions valid? Am Rev Respir Dis (1991) 1.42
Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen (2007) 1.41
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol (2000) 1.40
ZAP-70 expression remains stable in chronic lymphocytic leukaemia. Int J Lab Hematol (2007) 1.39
Pain after vasectomy. Anaesthesia (1998) 1.39
Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man. Circulation (1977) 1.38
A comparative study of the quality and availability of health information used to facilitate cost burden analysis of diabetes and hypertension in the Caribbean. West Indian Med J (2008) 1.38
Comparative response of male and female patients with coronary artery disease to exercise rehabilitation. Eur Heart J (1984) 1.38
"Healthy alliances?"--other sexual health services and their views of genitourinary medicine. Genitourin Med (1995) 1.38
Personal Paper: Orthopaedic scooter. Br Med J (Clin Res Ed) (1986) 1.37
The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J Biol Chem (2001) 1.37
Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation (1986) 1.37
Effect of postural changes, nitroglycerin and verapamil on diastolic ventricular function as determined by radionuclide angiography in normal subjects. J Am Coll Cardiol (1988) 1.35
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol (1997) 1.34
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Indian Heart J (2001) 1.33
Behaviour of canine pulmonary vagal afferent receptors during sustained acute pulmonary venous pressure elevation. J Physiol (1987) 1.32
Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. Arch Intern Med (1998) 1.31